STERILE NEEDLES - HUMAN-IMMUNODEFICIENCY-VIRUS IN DIABETIC INTRAVENOUS-DRUG-USERS

被引：0
|
作者：
FERNANDO, D
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1992年 / 267卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1340 / 1340
页数：1
相关论文
共 50 条
  • [31] NEUROLOGIC AND NEUROPSYCHOLOGICAL MANIFESTATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN INTRAVENOUS-DRUG-USERS WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME - RELATIONSHIP TO HEAD-INJURY
    MARDER, K
    STERN, Y
    MALOUF, R
    TANG, MX
    BELL, K
    DOONEIEF, G
    ELSADR, W
    GOLDSTEIN, S
    GORMAN, J
    RICHARDS, M
    SANO, M
    SORRELL, S
    TODAK, G
    WILLIAMS, JBW
    EHRHARDT, A
    MAYEUX, R
    ARCHIVES OF NEUROLOGY, 1992, 49 (11) : 1169 - 1175
  • [32] HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN HETEROSEXUAL INTRAVENOUS-DRUG-USERS IN SAN-FRANCISCO
    CHAISSON, RE
    MOSS, AR
    ONISHI, R
    OSMOND, D
    CARLSON, JR
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (02) : 169 - 172
  • [33] DIFFERENCES IN RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION AMONG MALE AND FEMALE INTRAVENOUS-DRUG-USERS
    SOLOMON, L
    ASTEMBORSKI, J
    WARREN, D
    MUNOZ, A
    COHN, S
    VLAHOV, D
    NELSON, KE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (08) : 892 - 898
  • [34] DIFFERENCES IN RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION AMONG MALE AND FEMALE INTRAVENOUS-DRUG-USERS
    NICOLOSI, A
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (02) : 188 - 189
  • [35] INFECTIVE ENDOCARDITIS IN INTRAVENOUS-DRUG-USERS - A COMPARISON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-NEGATIVE AND 1-POSITIVE PATIENTS
    NAHASS, RG
    WEINSTEIN, MP
    BARTELS, J
    GOCKE, DJ
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04): : 967 - 970
  • [36] DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY POLYMERASE CHAIN-REACTION IN A COHORT OF SERONEGATIVE INTRAVENOUS-DRUG-USERS
    FARZADEGAN, H
    VLAHOV, D
    SOLOMON, L
    MUNOZ, A
    ASTEMBORSKI, J
    TAYLOR, E
    BURNLEY, A
    NELSON, KE
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02): : 327 - 331
  • [37] HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I DISEASE IN ARGENTINE INTRAVENOUS-DRUG-USERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ZALA, C
    ZAPIOLA, I
    BOUZAS, MB
    BENETUCCI, J
    LOPEZ, L
    GALLO, D
    HANSON, C
    MUCHINIK, GR
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (08): : 870 - 871
  • [38] MODELING INCIDENCE RATE RATIO AND RATE DIFFERENCE - ADDITIVITY OR MULTIPLICATIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS PARENTERAL AND SEXUAL TRANSMISSION AMONG INTRAVENOUS-DRUG-USERS
    LEITE, MLC
    NICOLOSI, A
    OSELLA, AR
    MOLINARI, S
    COZZOLINO, E
    VELATI, C
    LAZZARIN, A
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (01) : 16 - 24
  • [39] PREVALENCE AND INCIDENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AMONG INTRAVENOUS-DRUG-USERS IN SOUTH-FLORIDA
    CHITWOOD, DD
    COMERFORD, M
    ANDERSON, RM
    ROSS, S
    FISHWICK, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (04) : 771 - 771
  • [40] DRUG-ABUSE TREATMENT AS A STRATEGY TO PREVENT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AMONG INTRAVENOUS-DRUG-USERS - HOW CAN WE MAXIMIZE PREVENTION OF INFECTION
    WEST, AP
    ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (08) : 1493 - 1496
12345